{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:13:11Z","timestamp":1740107591981,"version":"3.37.3"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"DOI":"10.1007\/s00592-024-02272-7","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T19:01:47Z","timestamp":1712084507000},"page":"1081-1082","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reply to comment on: Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyser database"],"prefix":"10.1007","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7804-1740","authenticated-orcid":false,"given":"Wolfgang","family":"Rathmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karel","family":"Kostev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,2]]},"reference":[{"key":"2272_CR1","first-page":"1443","volume":"59","author":"L Du","year":"2024","unstructured":"Du L, Li Z, Lan P, Huang H, Cheng W, Xia J (2024) Comment on: Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer database. Acta Diabetol 59:1443\u20131451","journal-title":"Acta Diabetol"},{"issue":"11","key":"2272_CR2","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1007\/s00592-022-01943-7","volume":"59","author":"W Rathmann","year":"2022","unstructured":"Rathmann W, Kostev K (2022) Association of glucose-lowering drugs with incident stroke and transient ischaemic attacks in primary care patients with type 2 diabetes: disease analyzer database. Acta Diabetol 59(11):1443\u20131451. https:\/\/doi.org\/10.1007\/s00592-022-01943-7","journal-title":"Acta Diabetol"},{"issue":"8","key":"2272_CR3","doi-asserted-by":"publisher","first-page":"e13997","DOI":"10.1111\/eci.13997","volume":"53","author":"F Mahmoud","year":"2023","unstructured":"Mahmoud F, Mullen A, Sainsbury C et al (2023) Meta-analysis of factors associated with antidiabetic drug prescribing for type 2 diabetes mellitus. Eur J Clin Invest 53(8):e13997. https:\/\/doi.org\/10.1111\/eci.13997","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"2272_CR4","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3390\/ijms24010351","volume":"24","author":"CY Hsieh","year":"2022","unstructured":"Hsieh CY, Sung SF (2022) From kidney protection to stroke prevention: the potential role of sodium glucose cotransporter-2 inhibitors. Int J Mol Sci 24(1):351. https:\/\/doi.org\/10.3390\/ijms24010351","journal-title":"Int J Mol Sci"},{"key":"2272_CR5","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2022.0421","author":"JS Kim","year":"2024","unstructured":"Kim JS, Lee G, Park KI, Oh SW (2024) Comparative effect of glucose-lowering drugs for type 2 diabetes mellitus on stroke prevention: a systematic review and network meta-analysis. Diabetes Metab J. https:\/\/doi.org\/10.4093\/dmj.2022.0421","journal-title":"Diabetes Metab J"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-024-02272-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-024-02272-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-024-02272-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T08:05:32Z","timestamp":1723795532000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-024-02272-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,2]]},"references-count":5,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["2272"],"URL":"https:\/\/doi.org\/10.1007\/s00592-024-02272-7","relation":{},"ISSN":["1432-5233"],"issn-type":[{"type":"electronic","value":"1432-5233"}],"subject":[],"published":{"date-parts":[[2024,4,2]]},"assertion":[{"value":"23 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"W.R. reports the receipt of consulting fees for attending educational sessions by Novo Nordisk outside of the topic of the current work. K.K. reports no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Disease Analyzer database, used for analysis, contains anonymized electronic patient records. Patient data was analyzed in aggregated form without individual data being available. Patient consent and ethical approval was waived due to national and European legislation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Informed consent"}}]}}